blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1027608

EP1027608 - PROTEIN FRAGMENT COMPLEMENTATION ASSAYS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.11.2010
Database last updated on 03.10.2024
Most recent event   Tooltip11.07.2014Change - lapse in a contracting statepublished on 13.08.2014  [2014/33]
Applicant(s)For all designated states
Odyssey Thera, Inc.
4550 Norris Canyon Road, Suite 140
San Ramon, CA 94583 / US
[2010/03]
Former [2005/27]For all designated states
Odyssey Thera, Inc.
4550 Norris Canyon Road, Suite 140
San Ramon, CA 94583 / US
Former [2000/33]For all designated states
UNIVERSITE DE MONTREAL
6128, Succursale A
Montréal, Québec H3C 3J7 / CA
Inventor(s)01 / MICHNICK, Stephen, William, Watson
330 Grosvenor
Westmount, Quebec H3C 2M2 / CA
02 / PELLETIER, Joelle, Nina
Apartment 611, 10 Rosemount Avenue
Westmount, Quebec H3Y 3K4 / CA
03 / REMY, Ingrid
8526 Berri
Montreal, Quebec H2P 2G4 / CA
[2000/33]
Representative(s)Schüssler, Andrea
Kanzlei Huber & Schüssler
Truderinger Strasse 246
81825 München / DE
[N/P]
Former [2000/33]Schüssler, Andrea, Dr.
Kanzlei Huber & Schüssler Truderinger Strasse 246
81825 München / DE
Application number, filing date99936199.130.07.1999
[2000/33]
WO1999CA00702
Priority number, dateCA1998224434930.07.1998         Original published format: CA 2244349
US1998012485030.07.1998         Original published format: US 124850
[2000/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0007038
Date:10.02.2000
Language:EN
[2000/06]
Type: A2 Application without search report 
No.:EP1027608
Date:16.08.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2000 takes the place of the publication of the European patent application.
[2000/33]
Type: B1 Patent specification 
No.:EP1027608
Date:20.01.2010
Language:EN
[2010/03]
Search report(s)International search report - published on:EP04.05.2000
ClassificationIPC:G01N33/58, G01N33/566, G01N33/68
[2000/33]
CPC:
G01N33/566 (EP); C12N15/1055 (EP); G01N33/581 (EP);
G01N33/68 (EP); G01N2500/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/33]
TitleGerman:EIWEISBRUCHSTÜCKERGÄNZUNGSTESTS[2000/33]
English:PROTEIN FRAGMENT COMPLEMENTATION ASSAYS[2000/33]
French:DOSAGES DE COMPLEMENTATION DE FRAGMENTS PROTEIQUES[2009/28]
Former [2000/33]DOSAGES DE COMPLEMENTATION PROTEINES-FRAGMENTS
Entry into regional phase07.06.2000National basic fee paid 
07.06.2000Designation fee(s) paid 
07.06.2000Examination fee paid 
Examination procedure07.06.2000Examination requested  [2000/33]
20.07.2001Despatch of a communication from the examining division (Time limit: M07)
28.02.2002Reply to a communication from the examining division
31.08.2004Despatch of a communication from the examining division (Time limit: M06)
09.03.2005Reply to a communication from the examining division
05.09.2006Despatch of a communication from the examining division (Time limit: M06)
14.03.2007Reply to a communication from the examining division
30.05.2008Despatch of a communication from the examining division (Time limit: M06)
09.12.2008Reply to a communication from the examining division
20.01.2009Despatch of a communication from the examining division (Time limit: M04)
24.04.2009Reply to a communication from the examining division
13.07.2009Communication of intention to grant the patent
13.11.2009Fee for grant paid
13.11.2009Fee for publishing/printing paid
Opposition(s)21.10.2010No opposition filed within time limit [2010/52]
Fees paidRenewal fee
31.07.2001Renewal fee patent year 03
31.07.2002Renewal fee patent year 04
14.07.2003Renewal fee patent year 05
14.07.2004Renewal fee patent year 06
27.07.2005Renewal fee patent year 07
27.07.2006Renewal fee patent year 08
26.07.2007Renewal fee patent year 09
14.07.2008Renewal fee patent year 10
10.07.2009Renewal fee patent year 11
Penalty fee
Penalty fee Rule 85a EPC 1973
07.06.2000AT   M01   Fee paid on   07.06.2000
07.06.2000BE   M01   Fee paid on   07.06.2000
07.06.2000CH   M01   Fee paid on   07.06.2000
07.06.2000CY   M01   Fee paid on   07.06.2000
07.06.2000DE   M01   Fee paid on   07.06.2000
07.06.2000DK   M01   Fee paid on   07.06.2000
07.06.2000ES   M01   Fee paid on   07.06.2000
07.06.2000FI   M01   Fee paid on   07.06.2000
07.06.2000FR   M01   Fee paid on   07.06.2000
07.06.2000GB   M01   Fee paid on   07.06.2000
07.06.2000GR   M01   Fee paid on   07.06.2000
07.06.2000IE   M01   Fee paid on   07.06.2000
07.06.2000IT   M01   Fee paid on   07.06.2000
07.06.2000LU   M01   Fee paid on   07.06.2000
07.06.2000MC   M01   Fee paid on   07.06.2000
07.06.2000NL   M01   Fee paid on   07.06.2000
07.06.2000PT   M01   Fee paid on   07.06.2000
07.06.2000SE   M01   Fee paid on   07.06.2000
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY20.01.2010
GR21.04.2010
PT20.05.2010
AT30.07.2010
FI30.07.2010
SE31.07.2010
[2014/33]
Former [2014/24]CY20.01.2010
GR21.04.2010
PT20.05.2010
AT30.07.2010
FI30.07.2010
SE31.07.2010
Former [2013/48]CY20.01.2010
GR21.04.2010
PT20.05.2010
AT30.07.2010
FI30.07.2010
SE31.07.2010
Former [2013/08]CY20.01.2010
GR21.04.2010
PT20.05.2010
AT30.07.2010
FI30.07.2010
GB30.07.2010
SE31.07.2010
Former [2012/41]CY20.01.2010
GR21.04.2010
PT20.05.2010
AT30.07.2010
FI30.07.2010
GB30.07.2010
IE30.07.2010
SE31.07.2010
Former [2012/01]CY20.01.2010
GR21.04.2010
PT20.05.2010
AT30.07.2010
FI30.07.2010
GB30.07.2010
IE30.07.2010
Former [2011/35]CY20.01.2010
GR21.04.2010
PT20.05.2010
FI30.07.2010
GB30.07.2010
IE30.07.2010
Former [2011/25]CY20.01.2010
GR21.04.2010
PT20.05.2010
FI30.07.2010
FR02.08.2010
Former [2010/44]PT20.05.2010
Cited inInternational search[PX]WO9844350  (UNIV LELAND STANFORD JUNIOR) [PX] 1-66 * claim - * * page 5, line 4 - line 17 * * page 13, line 3 - line 12 * * page 15, line 10 - line 30 * * page 19, line 5 - line 27 * * page 27, line 7 - line 28 * * example 11 *;
 [PX]WO9834120  (PELLETIER JOELLE NINA ;REMY INGRID (CA); UNIV MONTREAL (CA); MICHN) [PX] 1-66 * the whole document *;
 [XY]  - PELLETIER J N ET AL, "A PROTEIN COMPLEMENTATION ASSAY FOR DETECTION OF PROTEIN-PROTEIN INTERACTIONS IN VIVO", PROTEIN ENGINEERING,GB,OXFORD UNIVERSITY PRESS, SURREY, vol. 10, no. SUPPL. 01, ISSN 0269-2139, page 89, XP002064563 [X] 1-66 * the whole document * [Y] 1-66

DOI:   http://dx.doi.org/10.1093/protein/10.1.89
 [YD]  - ROSSI F ET AL, "MONITORING PROTEIN-PROTEIN INTERACTIONS IN INTACT EUKARYOTIC CELLS BY BETA-GALACTOSIDASE COMPLEMENTATION", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 94, ISSN 0027-8424, page 8405-8410, XP002064565 [YD] 1-66 * page 8410 *

DOI:   http://dx.doi.org/10.1073/pnas.94.16.8405
Examination   - WATOWICH ET AL, "Activation and inhibition of EpoR function:Role of receptor dimerization", MOLECULAR CELL BIOLOGY, (1994), vol. 14, pages 3535 - 3549
    - MIURA ET AL, "Inactivation of EpoRfunction by point mutations in a region having homology with other cytokine receptors", MOLECULAR CELL BIOLOGY, (1993), vol. 13, pages 1788 - 1795
    - QUELLE ET AL, "Mutations in the WSAWSE and cytosolic domains of the EpoR affect signal transduction and ligand binding and interalization.", MOLECULAR CELL BIOLOGY, (1992), vol. 12, pages 4553 - 4561
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.